Haemonetics Corp (HAE) President & CEO Christopher Simon, Sold $5.4 million of Shares
- By insider
President & CEO of Haemonetics Corp (HAE) Christopher Simon, sold 57,587 shares of HAE on 05/13/2019 at an average price of $94.51 a share. The total sale was $5.4 million.
Haemonetics Corp is a health care company. It provides products enabling the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes. Haemonetics Corp has a market cap of $5.19 billion; its shares were traded at around $101.79 with a P/E ratio of 96.93 and P/S ratio of 5.54. Haemonetics Corp had annual average EBITDA growth of 2.00% over the past ten years.
Warning! GuruFocus has detected 2 Warning Sign with HAE. Click here to check it out.
The intrinsic value of HAE
CEO Recent Trades:
President & CEO Christopher Simon, sold 57,587 shares of HAE stock on 05/13/2019 at the average price of $94.51. The price of the stock has increased by 7.7% since.
Directors and Officers Recent Trades:
SVP, Global Human Resources Jacqueline Scanlan sold 1,508 shares of HAE stock on 05/14/2019 at the average price of $100. The price of the stock has increased by 1.79% since.
For the complete insider trading history of HAE, click here
.This article first appeared on GuruFocus.
Warning! GuruFocus has detected 2 Warning Sign with HAE. Click here to check it out.
The intrinsic value of HAE
